The Cellular Biochemistry and Biophysics Program was established to study basic mechanisms of cell biology using methods of biochemistry and structural biology. During the current funding period, it advanced from a """"""""developing program"""""""" to an established program with 11 members. The focus of the research is presented with two major thrusts: (1) tissue architecture and assembly and (2) cell organization and function. Major scientific contributions from this program include the identification of new signaltransducing molecules such as disintegrins or beta-catenin, the elucidation of the role of hsp molecular chaperones in protein folding, the description of mechanisms of vesicle budding, and the elucidation of the structures of the AMP-RNA aptamer complex, the p53-DNA complex and the cyclin A-CDK2 complex. Intra- and interprogrammatic interactions are fostered through a variety of seminars, retreats and frequent informal contact. Program members attend both a program seminar series and a joint series with the structural biology faculty at Rockefeller University and the weekly Work-in-Progress meetings. The Program Leader, Dr. James Rothman, was recruited to MSKCC in 1991 and led the recruitment to assemble the present faculty. Future plans are to add two to three new members with interests in cell signaling, regulation and development.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA008748-37
Application #
6563637
Study Section
Project Start
2002-01-30
Project End
2002-12-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
37
Fiscal Year
2002
Total Cost
$157,506
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Choi, Karmel W; Shaffer, Kelly M; Zale, Emily L et al. (2018) Early Risk and Resiliency Factors Predict Chronic Posttraumatic Stress Disorder in Caregivers of Patients Admitted to a Neuroscience ICU. Crit Care Med 46:713-719
Kantor, Elizabeth D; Newton, Christina C; Giovannucci, Edward L et al. (2018) Glucosamine use and risk of colorectal cancer: results from the Cancer Prevention Study II Nutrition Cohort. Cancer Causes Control 29:389-397
Mizrachi, Aviram; Migliacci, Jocelyn C; Montero, Pablo H et al. (2018) Neck recurrence in clinically node-negative oral cancer: 27-year experience at a single institution. Oral Oncol 78:94-101
Fassel, Hannah; Bussel, James B; Roberts, Stephen S et al. (2018) Romiplostim for Immune Thrombocytopenia in Neuroblastoma Patients Receiving Chemotherapy. J Pediatr Hematol Oncol :
Lezcano, Cecilia; Shoushtari, Alexander N; Ariyan, Charlotte et al. (2018) Primary and Metastatic Melanoma With NTRK Fusions. Am J Surg Pathol 42:1052-1058
Bello, Danielle M; Russell, Christy; McCullough, Debbie et al. (2018) Lymph Node Status in Breast Cancer Does Not Predict Tumor Biology. Ann Surg Oncol 25:2884-2889
Coriddi, Michelle; Kenworthy, Elizabeth; Weinstein, Andrew et al. (2018) The importance of indocyanine green near-infrared fluorescence angiography in perfusion assessment in vascularized omentum lymphatic transplant. J Surg Oncol 118:109-112
Korenstein, Deborah; Husain, Solomon; Gennarelli, Renee L et al. (2018) Impact of Clinical Specialty on Attitudes Regarding Overuse of Inpatient Laboratory Testing. J Hosp Med 13:844-847
Wang, Lucia; Guillen, Valeria S; Sharma, Naina et al. (2018) New Class of Selective Estrogen Receptor Degraders (SERDs): Expanding the Toolbox of PROTAC Degrons. ACS Med Chem Lett 9:803-808
Offin, Michael; Rizvi, Hira; Tenet, Megan et al. (2018) Tumor Mutation Burden and Efficacy of EGFR-Tyrosine Kinase Inhibitors in Patients with EGFR-Mutant Lung Cancers. Clin Cancer Res :

Showing the most recent 10 out of 8799 publications